Â¥
22.99
Jan 16
New Key Statistics Module, Z-Score and F-Score
SZSE:301258 Key Ratios
Market Cap ¥ M | 2,107.49 |
Enterprise Value ¥ M | 731.20 |
P/E(ttm) | 113.81 |
PE Ratio without NRI | 84.52 |
Forward PE Ratio | -- |
Price/Book | 1.11 |
Price/Sales | 5.14 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 2.21 |
Revenue (TTM) ¥ M | 413.00 |
EPS (TTM) ¥ | 0.20 |
Beneish M-Score | -1.71 |
10-y EBITDA Growth Rate % | 18.30 |
5-y EBITDA Growth Rate % | -0.90 |
y-y EBITDA Growth Rate % | -88.80 |
EV-to-EBIT | 36.59 |
EV-to-EBITDA | 36.59 |
PEG | -- |
Shares Outstanding M | 91.67 |
Net Margin (%) | 4.57 |
Operating Margin % | -0.11 |
Pre-tax Margin (%) | 4.81 |
Quick Ratio | 11.75 |
Current Ratio | 12.98 |
ROA % (ttm) | 0.90 |
ROE % (ttm) | 0.98 |
ROIC % (ttm) | -0.07 |
Dividend Yield % | 2.59 |
Altman Z-Score | 7.98 |
SZSE:301258 Number of Guru Trades
SZSE:301258 Volume of Guru Trades
Gurus Latest Trades with SZSE:301258
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301258 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Suzhou Fushilai Pharmaceutical Co Ltd Insider Transactions
No Available Data